NCT00595543View on ClinicalTrials.gov

Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%

PHASE4CompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Acute Pseudophakic Cystoid Macular Edema
Interventions
DRUG

Bromfenac

1 drop (in the eye) Instill one drop in the affected eye twice daily for three months

DRUG

Ketorolac

1 drop (in the eye) Instill one drop in the affected eye four times daily for three months

DRUG

Diclofenac

1 drop (in the eye) Instill one drop in the affected eye four times daily for three months

Trial Locations (1)

19124

Soll Eye Associates, Philadelphia

Sponsors

Lead Sponsor

Bp Consulting, Inc
All Listed Sponsors
lead

Bp Consulting, Inc

NETWORK

NCT00595543 - Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5% | Biotech Hunter | Biotech Hunter